Status:
COMPLETED
Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center
Lead Sponsor:
University of Minnesota
Conditions:
Pain
Pain, Acute
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.
Detailed Description
This is a level I randomized prospective outcomes study comparing two groups of patients. Within 15-30 minutes of planned wake-up Group 1 will receive 30 mcg of sublingual sufentanil and group 2 will ...
Eligibility Criteria
Inclusion
- \- Adult patients undergoing outpatient ambulatory surgery undergoing general anesthesia for orthopedic surgery
Exclusion
- non-english speaking patients
- patients who have allergy or intolerance to the study drugs or derivatives
Key Trial Info
Start Date :
October 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 4 2021
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT04387136
Start Date
October 14 2020
End Date
February 4 2021
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455